Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design

BACKGROUND: Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic) pancreatic ductal adenocarcinoma (PDAC). These patients are currently treated with ‘best supportive care’. Therefore, it is desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Doppenberg, D., Besselink, M. G., van Eijck, C. H. J., Intven, M. P. W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W. M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J. M. E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., Bruynzeel, A. M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801528/
https://www.ncbi.nlm.nih.gov/pubmed/36581914
http://dx.doi.org/10.1186/s12885-022-10419-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801528/
https://www.ncbi.nlm.nih.gov/pubmed/36581914
http://dx.doi.org/10.1186/s12885-022-10419-4

Ejemplares similares